Market Cycles can be one hell of a thing.
Elite has been beaten up so badly over the years but has seen revenues rise by 88% during it's last earning call.
These pharmaceuticals companies are always one drug away from hitting jackpot and this is worth a go.
NORTHVALE, NJ / ACCESSWIRE / September 12, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) for a generic...
